Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    PDS0101

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PDS Biotech Reports Q3 2025 Financials And Clinical Programs
    PDS Biotech Reports Q3 2025 Financials And Clinical Programs

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187197/37149/en/PDS-Biotech-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Clinical-Programs-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    PDS Biotech Reveals Strong Immunological Data For PDS0101
    PDS Biotech Reveals Strong Immunological Data For PDS0101

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184578/37149/en/PDS-Biotechnology-Announces-Translational-Data-Showing-Strong-Immunological-and-Clinical-Activity-of-PDS0101-and-PDS01ADC-Presented-at-SITC-2025.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    PDS Bio to Pursue Expedited Approval for PDS0101 in HPV16+ Cancer
    PDS Bio to Pursue Expedited Approval for PDS0101 in HPV16+ Cancer

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176464/37149/en/PDS-Biotech-to-Seek-Expedited-Approval-Pathway-for-PDS0101-in-HPV16-Positive-Head-and-Neck-Cancer.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share